John Snisarenko - Sep 22, 2021 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Signature
/s/ Brandon Fenn, Attorney-in-Fact
Stock symbol
OYST
Transactions as of
Sep 22, 2021
Transactions value $
$0
Form type
4
Date filed
9/24/2021, 04:44 PM
Next filing
Nov 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OYST Employee Stock Option (Right to Buy) Award $0 +20K $0.00 20K Sep 22, 2021 Common Stock 20K $12.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted on September 22, 2021 under the Oyster Point Pharma, Inc. 2019 Equity Incentive Plan. 1/4th of the options shall vest and become exercisable on August 25, 2022 and one thirty-sixth (1/36) of the remaining options shall vest monthly thereafter on the same day of the month (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2019 Equity Incentive Plan) through each such date.